allograft loss. 1 Currently, a major problem regarding improving the long-term outcomes of kidney transplantation is our incomplete un- biopsies. 15 Kidney allograft survival in patients with inflammation detected in fibrotic areas of indication biopsies has been reported to be significantly worse compared to patients with noninflammatory interstitial fibrosis. [16] [17] [18] Moreover, when interstitial inflammation was considered in the whole cortex (including scarred and nonscarred areas) and defined by the total inflammation score (ti), this information out- 
| PATIENTS AND METHODS

| Study population
This study enrolled all consecutive patients who underwent kidney transplantation across a negative complement-dependent cytotox- and 89 who were lost to follow-up in the first year posttransplantation. Patients who did not undergo a screening biopsy (contraindication, refusal, or not conducted) or for whom the screening biopsy was performed but was not adequate according to the international Banff classification were also excluded from the analysis (n = 171).
| Kidney allograft histology
All biopsies (2260 for-cause biopsies performed within the first year after transplantation and 1539 protocol biopsies performed at 1 year)
were assessed by the local pathologist (MR, JV, CG, JPDVH) using the 
| Assessment of interobserver reproducibility
| Clinical data
Clinical data were obtained from a prospective database, Données Interobserver reproducibility was assessed using Cohen's kappa coefficient. 22 Kappa coefficient estimations were repeated 1000 times using bootstrap samples to derive 95% confidence intervals (CI). 
| Statistical analysis
| RESULTS
| Patient characteristics
We considered 1539 patients who received kidney transplants be- 
| Determinants of i-IF/TA at 1 year after transplantation
The parameters associated with i-IF/TA at 1 year after transplantation in univariate analysis are provided in Table 3 .
The independent determinants of i-IF/TA at 1-year posttransplantation in multivariable analysis included the following (Table 4) 
| DISCUSSION
In this study, performed in a prospective cohort of 1539 kidney trans- (1) the strength of the association between TCMR and i-IF/TA; The current era of more potent immunosuppression has altered the presentation of rejection, resulting in a reduced frequency of acute episodes, 28 the emergence of subclinical and chronic forms of rejection, 29 and the prominence of allograft scarring due to improved allograft survival. 30 However, the current Banff criteria for the diagnosis of TCMR in kidney allografts were defined in 1991 by infiltration of the interstitium by T cells and macrophages and tubulitis (i and t scores) only in nonscarred areas of the allograft. 31 Our study showed that interstitial inflammation in scarred areas is also associated with tubulitis in atro- 
